stride study semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial Evaluating the Cardiovascular Benefits of – 🎙️NEW #ADA2025 #LBCT Interview 💫Dr

Joshua Silva, MD Nov 7, 2025 13 min read Updated: Apr 17 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As GLP-1 and GLP-1/GIP medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) continue to transform medical weight management, one question comes up repeatedly: Do these medications cause muscle lossor even muscle wasting

But the effects that a pause may have on your body depends on why youre taking the medication in the first place, Korner said

Read on to learn how to inject semaglutide safely so you can use it as part of your weight loss plan

Strategic Considerations for Stakeholders For Innovators (Novo Nordisk): Focus will shift to next-generation GLP-1 analogs (e.g., CagriSema, amycretin)

Theres no getting around it: We are a part of nature, not apart from nature

Treatment with Wegovy is limited to 2 years and its long-term risks are still being studied